Biokin Pharma’s iza-bren has recorded another significant clinical victory, meeting the primary endpoint of its Panku-Lung01 lung cancer phase 3 trial at an interim analysis. The Chinese drugmaker disclosed the result in
More
The best chief financial officers share a quality that is difficult to name but immediately recognisable to anyone who has worked alongside one for long enough. As one analysis puts it, “while
More
In June 2026, the U.S. Department of the Treasury’s Office of Foreign Assets Control issued a series of new and amended Venezuela-related general licenses across multiple sectors. The licenses cover areas including
More
The competition for qualified legal professionals has reached unprecedented levels, creating serious challenges for law firms of all sizes across the United States. According to the U.S. Bureau of Labor Statistics, the
More
New York’s legal history is full of colourful figures, but few careers arc as dramatically as that of Sol Wachtler, whose wit ultimately outlasted his reputation. Wachtler served as Chief Judge of
More
London’s blue-chip index defied broader European weakness on Tuesday, advancing 0.16% as energy and consumer stocks provided strong support to the market. Germany’s DAX fell 0.48% and France’s CAC 40 slipped 0.18%,
More
The information technology sector saw notable price movements across twelve stocks during Tuesday’s intraday trading session, drawing the attention of market watchers. Technology stocks have continued to experience volatility in 2026, as
More
Kainos Group saw its share price surge following a positive trading update that caught the attention of investors across the FTSE 250 index. The Belfast-headquartered technology company has been among the standout
More
A new report backed by the Conservative Party claims households could save around £540 a year after 2030 if net zero regulations are abandoned in favour of cheaper energy. The figure comes
More
Australian plasma and vaccine specialist CSL posted signs of a meaningful recovery on Tuesday after a turbulent year marked by impairments, revenue downgrades, and an executive shakeup. The company’s fiscal 2026 report
More